Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed)

Document Type:Grants NoticeFunding Opportunity Number:PAR-23-169Funding Opportunity Title:Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed)Opportunity Category:DiscretionaryOpportunity Category Explanation: Funding Instrument Type:GrantCategory of Funding Activity:HealthCategory Explanation: Expected Number of Awards: CFDA Number(s):93.855 -- Allergy and Infectious Diseases ResearchCost Sharing or Matching Requirement:No Version:Synopsis 1Posted Date:Apr 20, 2023Last Updated Date:Apr 20, 2023Original Closing Date for Applications:Aug 01, 2025 Current Closing Date for Applications:Aug 01, 2025 Archive Date:Sep 06, 2025Estimated Total Program Funding: Award Ceiling:$350,000Award Floor: Document Type:Grants NoticeFunding Opportunity Number:PAR-23-169Funding Opportunity Title:Innovation for HIV Vaccine Discovery (R01 Clinical Trial Not Allowed)Opportunity Category:DiscretionaryOpportunity Category Explanation: Funding Instrument Type:GrantCategory of Funding

Activity:HealthCategory Explanation: Expected Number of Awards: CFDA Number(s):93.855 -- Allergy and Infectious Diseases ResearchCost Sharing or Matching Requirement:No Version:Synopsis 1Posted Date:Apr 20, 2023Last Updated Date:Apr 20, 2023Original Closing Date for Applications:Aug 01, 2025 Current Closing Date for Applications:Aug 01, 2025 Archive Date:Sep 06, 2025Estimated Total Program Funding: Award Ceiling:$350,000Award Floor: Eligible Applicants:Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses City or township governments Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities County governments Special district governments Native American tribal governments (Federally recognized) Private institutions of higher education Others (see text field entitled "Additional Information on Eligibility" for clarification) Public and State controlled institutions of higher education State governments Native American tribal organizations (other than Federally recognized tribal governments) Small businesses Independent school districtsAdditional Information on Eligibility:Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. Agency Name:National Institutes of HealthDescription:The purpose of this reissued Funding Opportunity Announcement (FOA) is to support high-risk, high-impact, early discovery research on vaccine approaches to prevent acquisition of or ongoing infection by HIV. In keeping with the high-risk, high-impact nature of this research, this FOA supports a Go/No-Go approach to funding high risk research, which is significantly different from most R01 projects. Continued funding for the full award duration is dependent upon achieving negotiated Go/No-Go criteria by the end of Year 2.Link to Additional Information:https://grants.nih.gov/grants/guide/pa-files/PAR-23-169.htmlGrantor Contact Information:If you have difficulty accessing the full announcement electronically, please contact: NIH Grants Information grantsinfo@nih.govSee Section VII. Agency Contacts within the full opportunity announcement for all other inquires.